Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-17

Clinical Trial Update: Alternative Options to Minimize Niacin-Induced Flushing [NA]

View source ↗

Summary

A completed clinical trial evaluated alternative strategies to minimize niacin-induced flushing in people with high cholesterol; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacin (nicotinic acid)

Snippet

Sponsor: Patrick Moriarty, MD, FACP, FACC | Conditions: Hypercholesterolemia, Flushing | NA | Status: COMPLETED | Results posted: 2014-03-17